Price target upside
Milestone Pharmaceuticals Inc. - Common Shares Price Target Upside or Downside
MIST price target upside based on the current price and analyst average.
Direct answer
Milestone Pharmaceuticals Inc. - Common Shares's analyst target implies +402.6%.
The average target is $6.33 compared with a recorded current price of $1.26.
This percentage is calculated from the verified average target and recorded market price.
Forecast evidence checked August 11, 2026.
Get free Milestone Pharmaceuticals Inc. - Common Shares email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $1.26
- Average price target
- $6.33
- High price target
- $8.00
- Low price target
- $2.00
- Target upside
- +402.6%
- Consensus rating
- none
- Analysts
- 6
- Evidence date
- August 11, 2026
- Valid through
- August 18, 2026